GGrantIndex
Sort

50,496 grants matching lung cancer

Mox 1: A Novel Mitogenic Oxidase

$643,253
J. David Lambeth · Emory University · R01 · FY2009 · CA

Bioengineering adipocytes for cancer therapy

$643,221
Nadav Ahituv · University Of California, San Francisco · R01 · FY2024 · CA

Gefitinib-sensitive EGF receptor mutants in lung cancer

$643,108
Jeffrey E Settleman · Massachusetts General Hospital · R01 · FY2009 · CA

Monitoring Response to Targeted Therapy in Non-Small Cell Lung Cancer Using 18F..

$643,071
Sanjiv S Gambhir · Stanford University · P50 · FY2012 · CA

Regulation of Ras-Dependent Signal Transduction Pathways

$643,054
Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Secondary Prevention through Surveillance and Intervention

$643,007
Lewis A Chodosh · University Of Pennsylvania · R01 · FY2020 · CA

Risk prediction methods

$642,941
Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

Design and characterization of bacterial population dynamics in solid tumor models

$642,937
Jeff M Hasty · University Of California, San Diego · R01 · FY2021 · EB

The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis

$642,928
William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA

Proteolytic disregulation of the S326C mutant OGG1 DNA repair enzyme

$642,889
Michele K Evans · National Institute On Aging · ZIA · FY2013 · AG

Personalized Task-Based Respiratory Motion Correction for Low-Dose PET/CT

$642,844
Chi Liu · Yale University · R01 · FY2021 · CA

Vascular, Pulmonary and Renal Injury

$642,777
Michael A Gimbrone · Brigham And Women'S Hospital · T32 · FY2011 · HL

Studies of Non-Ionizing Radiation-Related Cancer

$642,762
Peter D Inskip · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA

Large scale clinical and economic impact analysis of potentially malignant incidental findings in radiology reports

$642,718
Meliha Yetisgen · University Of Washington · R01 · FY2023 · CA

Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)

$642,698
Christopher I Li · Fred Hutchinson Cancer Center · U24 · FY2023 · CA

Core B. Clinical & Biomarkers Core

$642,684
Dorothy K Hatsukami · University Of Minnesota · P01 · FY2023 · CA

Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation

$642,665
Kevin R Krull · St. Jude Children'S Research Hospital · R01 · FY2015 · CA

Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation

$642,665
Kevin R Krull · St. Jude Children'S Research Hospital · R01 · FY2016 · CA

Engineering the Skin Immune System to Induce Systemic Immune Responses

$642,652
Louis D Falo · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AR

Engineering the Skin Immune System to Induce Systemic Immune Responses

$642,652
Louis D Falo · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AR

Advancing Digital Pathology through Novel Machine Learning Methodologies

$642,575
Saeed Hassanpour · Dartmouth College · R01 · FY2022 · LM

Protein and proteolytic activity biomarkers of early stage pancreatic cancer

$642,526
Paul Tempst · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA

Acquired Cross-Resistance through MYC Amplification in Small Cell Lung Cancer

$642,429
Benjamin J Drapkin · Ut Southwestern Medical Center · R01 · FY2025 · CA

Adenocarcinoma of the Lung: role of NNK susceptibility

$642,351
Margaret R Spitz · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA

New Fluorescent Caspase Detection Probes to Label Apoptotic Tumor Cells In Vivo

$642,235
Brian W Lee · Immunochemistry Technologies, Llc · R44 · FY2009 · CA